These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6459183)

  • 1. [Pilot-trial of treatment of leprosy by pig's thymosin combined with dapsone (author's transl)].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):198-200. PubMed ID: 6459183
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial with rifampicin in the treatment of leprosy.
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1976 Oct; 48(4 Suppl):775-80. PubMed ID: 800236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histoid leprosy: clinical and experimental observations (author's transl)].
    Li WZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Mar; 3(1):23-6. PubMed ID: 6458388
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 10. [Initial results of prospective controlled treatment trials in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1984; 46(3):207-19. PubMed ID: 6391013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leprosy in Bulgaria. Epidemiology, Clinical forms and treatment (author's transl)].
    Mikhailov P; Dimitrova I
    Z Hautkr; 1981 Oct; 56(20):1364-70. PubMed ID: 7197852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

  • 15. The control of neuritis in leprosy with clofazimine.
    Pfaltzgraff RE
    Int J Lepr Other Mycobact Dis; 1972; 40(4):392-8. PubMed ID: 4586401
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 18. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
    Ganapati R; Revankar CR; Naik SS
    Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of a daily dosage of dapsone combined with a single dose of rifampicin. Clinical, bacteriological and histopathological evaluation].
    Le KD; Nguyen N; Nguyen VM
    Acta Leprol; 1981; 85():75-82. PubMed ID: 6805238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.